Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance)
- Citation:
- Blood Adv vol 2 (24) 3608-17
- Year:
- 2018
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 8
- Parents:
- None
- Children:
- None
- Pharmas:
- Takeda
- Grants:
- U10CA180821, U10CA180882, U10CA180836, U10CA180850, U10CA180866, U10CA180867, P30CA033572
- Corr. Author:
- Authors:
- Gail J. Roboz Sumithra J. Mandrekar Pinkal Desai Kristina Laumann Alison R. Walker Eunice S. Wang Jonathan E. Kolitz Bayard L. Powell Eyal C. Attar Wendy Stock Clara D. Bloomfield Jessica Kohlschmidt Krzysztof Mrózek Duane C. Hassane Levi Garraway Judit Jané-Valbuena Michele Baltay Adam Tracy Guido Marcucci Richard M. Stone Richard A. Larson
- Networks:
- CA043, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NY158, LAPS-OH007, NC002, NORTHWELL, NY018
- Study
- CALGB-11002
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: